ストックスクリーナーアプリを入手
205.03
0.52%
-1.08
プレマーケット:
205.75
0.72
+0.35%
前日終値:
$206.11
開ける：
$206.11
24時間の取引高:
7.29M
Relative Volume:
1.03
時価総額：
$362.65B
収益：
$62.82B
当期純損益:
$3.62B
株価収益率:
100.85
EPS:
2.0331
ネットキャッシュフロー:
$17.82B
1週間 パフォーマンス:
+0.56%
1か月 パフォーマンス:
-0.80%
6か月 パフォーマンス:
-6.40%
1年 パフォーマンス:
+9.55%
1日の値動き範囲:
$203.56
$207.01
1週間の範囲:
$203.56
$214.87
52週間の値動き範囲:
$176.57
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Compare ABBV vs LLY, JNJ, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
205.03 | 362.65B | 62.82B | 3.62B | 17.82B | 2.0331 |
LLY
Lilly Eli Co
|
987.05 | 880.19B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
224.62 | 540.71B | 96.36B | 21.04B | 17.80B | 8.6488 |
AZN
Astrazeneca Plc
|
184.92 | 286.78B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
148.36 | 283.08B | 54.66B | 13.58B | 16.05B | 7.0171 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-21 | 開始されました | Canaccord Genuity | Buy |
| 2026-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-02-20 | 開始されました | Barclays | Overweight |
| 2026-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 再開されました | UBS | Neutral |
| 2025-12-10 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-04 | ダウングレード | DZ Bank | Buy → Hold |
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? - The Motley Fool
Number of shareholders of AbbVie, Inc. CDR (CAD Hedged) – NEO:ABBV - TradingView
AbbVie Announces $1.4B Manufacturing Campus in Durham, NC | 2026News and Statistics - IndexBox
AbbVie to Present at Bank of America Securities Healthcare Conference on May 6, 2026 - geneonline.com
AbbVie to Present at the Bank of America Securities Healthcare Conference - marketscreener.com
Want Reliable Dividend Income in May? These 2 Stocks Deliver - The Motley Fool
Glenwood Academy students, AbbVie scientists team up for science fair projects - The Lansing Journal
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases at 2026 Digestive Disease Week - Investing News Network
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - Yahoo Finance
AbbVie presents IBD data at digestive disease conference By Investing.com - Investing.com Canada
AbbVie presents IBD data at digestive disease conference - Investing.com
Steroid use fell to 7% in AbbVie Crohn's study after 52 weeks - Stock Titan
Leukemia Therapeutics Market to Reach US$ 31.37 Billion by 2033 - openPR.com
OMC Financial Services LTD's AbbVie Inc(ABBV) Holding History - GuruFocus
ABBV Maintained by Evercore ISI Group -- Price Target Raised to $236 - GuruFocus
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook - The Globe and Mail
ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold? - TradingView
Federated Hermes MDT Market Neutral ETF's AbbVie Inc(ABBV) Holding History - GuruFocus
AVIP BlackRock Advantage Large Cap Value Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
Sarofim Equity Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
5,538 Shares in AbbVie Inc. $ABBV Acquired by Legacy Edge Advisors LLC - MarketBeat
Kornitzer Capital Management Inc. KS Acquires 5,020 Shares of AbbVie Inc. $ABBV - MarketBeat
Heritage Wealth Management, Inc.'s AbbVie Inc(ABBV) Holding History - GuruFocus
Wellment Financial's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie (ABBV) Reports Q1 Revenue Growth Despite Earnings Miss - GuruFocus
AB Sustainable Thematic Balanced Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat - MarketBeat
Strs Ohio Has $181.81 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
PFA Pension Forsikringsaktieselskab Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
Robertson Stephens Wealth Management LLC Acquires 34,246 Shares of AbbVie Inc. $ABBV - MarketBeat
Horizon Investments LLC Has $31.65 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Upgraded to Strong-Buy at DZ Bank - MarketBeat
Benjamin Edwards Inc. Has $77.83 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Artemis Investment Management LLP Has $160.86 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
AbbVie (NYSE:ABBV) Updates Q2 2026 Earnings Guidance - MarketBeat
AbbVie (NYSE:ABBV) Stock Price Down 2.2%Here's What Happened - MarketBeat
Thrivent Moderately Aggressive Allocation Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Inc. stock underperforms Friday when compared to competitors - MarketWatch
AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried - WSJ
ABBV Reiterated by Guggenheim -- Price Target Maintained at $249 - GuruFocus
10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga
U.S. Large Cap Growth Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie (NYSE: ABBV) Posts Q1 Revenue of $15B, Raises Guidance - Value The Markets
AbbVie Stock Beats Q1 Estimates as Skyrizi Hits $4.5B in a Single Quarter - TIKR.com
AbbVie option and FDA feedback reshape Aldeyra (Nasdaq: ALDX) drug plans - Stock Titan
Netflix, Cisco, Zoom And A Health Care Stock On CNBC's 'Final Trades'Cisco Systems (NASDAQ:CSCO) - Benzinga
SNS Financial Group LLC Has $2.97 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Oppenheimer & Co. Inc. Sells 8,094 Shares of AbbVie Inc. $ABBV - MarketBeat
Fifth Third Bancorp Grows Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
2.03%
0.41%
大文字化:
|
ボリューム (24 時間):